linerixibat

News

EU kicks off review of GSK's linerixibat in PBC

GSK's drug for severe itching in patients with autoimmune liver disease PBC is now under review in the EU and US, as Mirum Pharma tries to catch up.

News

GSK reveals data behind linerixibat for PBC 'relentless itch...

GSK reveals the data behind its linerixibat for itching associated with autoimmune liver disease PBC as it anticipates first approvals for the drug.

News

GSK drug raises hopes for patients with PBC itch

GSK has reported promising results with a drug to treat the severe itching that plagues patients with rare cholestatic liver disease primary biliary cholangitis (PBC).

EU kicks off review of GSK's linerixibat in PBC

GSK reveals data behind linerixibat for PBC 'relentless itch...

GSK drug raises hopes for patients with PBC itch

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Editor's Picks